BECRO Clinical Facility General Clinic "Eftychios Patsidis"

The BECRO Clinical Facility General Clinic "Eftychios Patsidis" is conducting studies that target pain relief through a fixed‑dose combination of ibuprofen and paracetamol, aiming to demonstrate bioequivalence with separate agents.

• Evaluation of analgesic bioequivalence
• Fixed‑dose combination efficacy
• Safety profiling in healthy volunteers
• Regulatory compliance for pain therapies

These investigations support the development of convenient pain‑management options for patients with musculoskeletal conditions.

Research at the site focuses on inhaled therapy for asthma and chronic obstructive pulmonary disease (COPD), comparing a new fixed‑dose inhalation powder of fluticasone propionate and salmeterol xinafoate with an established reference product to assess relative bioavailability.

• Asthma maintenance treatment
• COPD exacerbation reduction
• Inhalation powder delivery performance
• Bioequivalence in healthy volunteers

The outcomes aim to confirm therapeutic consistency for long‑acting respiratory medications.

The clinic also evaluates symptomatic therapies for common cold, flu, and fever, testing combination products that address multiple signs and improve overall patient comfort.

• Symptom relief for upper respiratory infections
• Fever reduction strategies
• Combination therapy safety
• Effectiveness of multi‑symptom formulations

These studies help refine treatment options for everyday illnesses affecting the general population.